Chettab K - Search Results

1

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.

Duong MN, Cleret A, Matera EL, Chettab K, Mathé D, Valsesia-Wittmann S, Clémenceau B, Dumontet C. Duong MN, et al. Among authors: chettab k. Breast Cancer Res. 2015 Apr 24;17(1):57. doi: 10.1186/s13058-015-0569-0. Breast Cancer Res. 2015. PMID: 25908175 Free PMC article.

2

Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.

Tagoug I, Jordheim LP, Herveau S, Matera EL, Huber AL, Chettab K, Manié S, Dumontet C. Tagoug I, et al. Among authors: chettab k. Clin Cancer Res. 2013 Jul 1;19(13):3556-66. doi: 10.1158/1078-0432.CCR-12-3134. Epub 2013 May 14. Clin Cancer Res. 2013. PMID: 23674497

3

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents.

Chettab K, Roux S, Mathé D, Cros-Perrial E, Lafond M, Lafon C, Dumontet C, Mestas JL. Chettab K, et al. PLoS One. 2015 Aug 14;10(8):e0134247. doi: 10.1371/journal.pone.0134247. eCollection 2015. PLoS One. 2015. PMID: 26274324 Free PMC article.

4

Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies.

Cornet S, Mathé D, Chettab K, Evesque A, Matera EL, Trédan O, Dumontet C. Cornet S, et al. Among authors: chettab k. Mol Cancer Ther. 2016 Jun;15(6):1238-47. doi: 10.1158/1535-7163.MCT-15-0759. Epub 2016 Mar 17. Mol Cancer Ther. 2016. PMID: 26988998

5

Doxorubicin Delivery into Tumor Cells by Stable Cavitation without Contrast Agents.

Chettab K, Mestas JL, Lafond M, Saadna DE, Lafon C, Dumontet C. Chettab K, et al. Mol Pharm. 2017 Feb 6;14(2):441-447. doi: 10.1021/acs.molpharmaceut.6b00880. Epub 2017 Jan 20. Mol Pharm. 2017. PMID: 28107023

6

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding.

Hirz T, Matera EL, Chettab K, Jordheim LP, Mathé D, Evesque A, Esmenjaud J, Salles G, Dumontet C. Hirz T, et al. Among authors: chettab k. Oncotarget. 2017 Aug 18;8(42):72818-72834. doi: 10.18632/oncotarget.20350. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069828 Free PMC article.

7

Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.

Sauveur J, Matera EL, Chettab K, Valet P, Guitton J, Savina A, Dumontet C. Sauveur J, et al. Among authors: chettab k. Oncotarget. 2018 Apr 20;9(30):21141-21155. doi: 10.18632/oncotarget.24975. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765526 Free PMC article.

8

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells.

Jordheim LP, Chettab K, Cros-Perrial E, Matera EL, Dumontet C. Jordheim LP, et al. Among authors: chettab k. Pharmacology. 2018;102(3-4):161-168. doi: 10.1159/000491587. Epub 2018 Jul 26. Pharmacology. 2018. PMID: 30048976

9

Platelet concentrate supernatants alter endothelial cell mRNA and protein expression patterns as a function of storage length.

Sut C, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Chettab K, Dumontet C, Laradi S, Burnouf T, Garraud O, Cognasse F. Sut C, et al. Among authors: chettab k. Transfusion. 2018 Nov;58(11):2635-2644. doi: 10.1111/trf.14973. Epub 2018 Oct 16. Transfusion. 2018. PMID: 30325037

10

Characterization of T-DM1-resistant breast cancer cells.

Sauveur J, Conilh L, Beaumel S, Chettab K, Jordheim LP, Matera EL, Dumontet C. Sauveur J, et al. Among authors: chettab k. Pharmacol Res Perspect. 2020 Aug;8(4):e00617. doi: 10.1002/prp2.617. Pharmacol Res Perspect. 2020. PMID: 32583565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters